Use of a spreadsheet to quantitate the equilibrium binding of an allosteric modulator

European Journal of Pharmacology

Volumn 355, Issue 1, 1998, Pages 103-111

  Christopoulos, Arthur ^a,b   Mitchelson, Fred ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Allosteric interaction; C7 3 phth; Muscarinic receptor; Regression nonlinear; Spreadsheet

Indexed keywords

ATROPINE; HEPTANE 1,7 BIS(DIMETHYL 3' PHTHALIMIDOPROPYL)AMMONIUM BROMIDE; METHYLSCOPOLAMINE; MUSCARINIC RECEPTOR; QUINUCLIDINYL BENZILATE; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; COMPUTER PROGRAM; COMPUTER SIMULATION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; HEART ATRIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALLOSTERIC REGULATION; ANIMALS; CEREBRAL CORTEX; FEMALE; GUINEA PIGS; HEART ATRIA; MALE; N-METHYLSCOPOLAMINE; PHTHALIMIDES; QUINUCLIDINYL BENZILATE; RADIOLIGAND ASSAY; RATS; RECEPTORS, MUSCARINIC; REGRESSION ANALYSIS; SOFTWARE;

EID: 0031716806     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00476-2     Document Type: Article

References (32)

1. Black, J.W., Leff, P., 1983. Operational models of pharmacological agonism. Proc. R. Soc. London B 220, 141-162.
2. Bowen, W.P., Jerman, J.C., 1995. Nonlinear regression using spreadsheets. Trends Pharmacol. Sci. 16, 413-417.
3. Bowen, W.P., Jerman, J.C., Baxter, G.S., 1994. OPTIMA: simultaneous fitting of response curves to the operational model of agonism with Microsoft EXCEL. Br. J. Pharmacol. 112, 659 pp.
4. Caulfield, M.P., 1993. Muscarinic receptors - characterization, coupling and function. Pharmacol. Ther. 58, 319-379.
5. 2 muscarine receptors. Mol. Pharmacol. 46, 105-114.
6. Christopoulos, A., Loiacono, R., Mitchelson, F., 1993. Binding of the muscarine receptor antagonist heptane-1,7-bis-(dimethyl-3′-phthalimidopropyl)-ammonium bromide at cholinoceptor sites. Eur. J. Pharmacol. (Mol. Pharmacol. Sect.) 246, 1-8.
7. Christopoulos, A., Lanzafame, A., Mitchelson, F., 1998. Allosteric interactions at muscarinic cholinoceptors. Clin. Exp. Pharmacol. Physiol. 25, 184-194.
8. De Lean, A., Munson, P.J., Rodbard, D., 1978. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 253, E97-E102.
9. De Lean, A., Hancock, A.A., Lefkowitz, R.J., 1982. Validation and statistical analysis of a computer modelling method of quantitative analysis of radioligand binding data for a mixture of pharmacological receptor subtypes. Mol. Pharmacol. 21, 5-16.
10. Ehlert, F.J., 1988. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol. Pharmacol. 33, 187-194.
11. Fleming, W.W., Westfall, D.P., De La Lande, I.S., Jellet, L.B., 1972. Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues. J. Pharmacol. Exp. Ther. 181, 339-345.
12. Hancock, A.A., Bush, E.N., Stanisic, D., Kyncl, J.J., Lin, C.T., 1988. Data normalization before statistical analysis: keeping the horse before the cart. Trends Pharmacol. Sci. 9, 29-32.
13. Hulme, E.G., Birdsall, N.J.M., 1992. Strategy and tactics in receptor-binding studies. In: Hulme, E.G. (Ed.), Receptor-Ligand Interactions. IRL Press at Oxford University Press, New York, pp. 63-176.
14. Kenakin, T.P., 1997. Pharmacologic Analysis of Drug-Receptor Interaction, third edn. Lippincott-Raven Press, New York.
15. 2 receptors. Eur. J. Pharmacol. 316, 27-32.
16. Lazareno, S., Birdsall, N.J.M., 1995. Detection, quantitation, and verification of allosteric interactions of agents with labelled and unlabelled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. Mol. Pharmacol. 48, 362-378.
17. Lee, N.H., El-Fakahany, E.E., 1991. Allosteric antagonists of the muscarinic acetylcholine receptor. Biochem. Pharmacol. 42, 199-205.
18. Leff, P., Prentice, D.J., Giles, H., Martin, G.R., Wood, J., 1990. Estimation of agonist affinity and efficacy by direct, operational model fitting. J. Pharmacol. Methods 23, 225-237.
19. Mitchelson, F., 1975. Antimuscarinic action of an alkane-bis-ammonium compound alone and in combination with (+)-benzetimide. Eur. J. Pharmacol. 33, 237-246.
20. Motulsky, H.J., 1995. Intuitive Biostatistics. Oxford Univ. Press, Oxford.
21. Motulsky, H.J., Ransnas, L.A., 1987. Fitting curves to data using nonlinear regression: a practical and nonmathematical review. FASEB J. 1, 365-374.
22. Munson, P.J., 1983. LIGAND: a computerized analysis of ligand binding data. Methods Enzymol. 92, 543-577.
23. Munson, P.J., Rodbard, D., 1980. LIGAND. A versatile computerized approach for the characterization of ligand binding systems. Anal. Biochem. 107, 220-239.
24. Parker, R.B., Waud, D.R., 1971. Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation: I. agonists. J. Pharmacol. Exp. Ther. 177, 1-12.
25. Stockton, J.M., Birdsall, N.J.M., Burgen, A.S.V., Hulme, E.G., 1983. Modification of the binding properties of muscarinic receptors by gallamine. Mol. Pharmacol. 23, 551-557.
26. Tucek, S., Proška, J., 1995. Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. 16, 205-212.
27. Tucek, S., Musilkova, J., Nedoma, J., Proška, J., Shelkovnikov, S.W., Vorlicek, J., 1990. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors. Mol. Pharmacol. 38, 674-680.
28. 4) in rat forebrain. Mol. Pharmacol. 38, 267-273.
29. Waud, D.R., 1975. Analysis of dose-response curves. In: Daniel, E.E., Paton, M. (Eds.), Methods in Pharmacology: Smooth Muscle, Vol. 3. Plenum, New York, pp. 471-506.
30. Waud, D.R., 1987. Model building and dose-response curves. In: Black, J.W., Jenkinson, D.H., Gerskowitch, V.P. (Eds.), Perspectives on Receptor Classification. Alan R. Liss, New York, pp. 139-156.
31. Waud, D.R., Parker, R.B., 1971. Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation: II. Competitive antagonists. J. Pharmacol. Exp. Ther. 177, 13-24.
32. Waud, D.R., Son, L.S., Waud, B.E., 1978. Kinetic and empirical analysis of dose-response curves illustrated with a cardiac example. Life Sci. 22, 1275-1286.